Bath & Body Works Stock Pops After Beat-And-Raise Quarter
Bath & Body Works stock is higher Monday after the retailer reported better-than-expected results and raised its full-year forecast.


Bath & Body Works (BBWI) stock is trading notably higher Monday after the specialty retailer beat top- and bottom-line expectations for its fiscal third quarter and raised its full-year outlook.
In its quarter ended November 2, Bath & Body Works said its revenue increased 3% year over year to $1.6 billion. Its earnings per share (EPS) decreased 5.8% from the year-ago period to 49 cents.
"Our strong results exceeded the high end of our net sales and earnings per diluted share guidance," said Bath & Body Works CEO Gina Boswell in a statement. "As a result, we are raising our full-year guidance to fully reflect this outperformance."
From just $107.88 $24.99 for Kiplinger Personal Finance
Be a smarter, better informed investor.

Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The results topped analysts' expectations. Wall Street was anticipating revenue of $1.58 billion and earnings of 47 cents per share, according to CNBC.
As its CEO mentioned, Bath & Body Works increased its full-year outlook following the strong quarter. The company now expects to revenue to decline between 2.5% and 1.7% and earnings per share to arrive between $3.15 to $3.28. The retailer had previously said it expected revenue to be down between 4% and 2% and earnings per share of $3.06 to $3.26.
"Innovation across our core products, adjacencies, and collaborations is resonating with both new and existing customers supported by the investments we have made in marketing and technology," Boswell said. "As we enter the critical holiday period, I am pleased with our strong execution and the momentum we are building, as we drive towards sustainable, long-term profitable growth."
Is Bath & Body Works stock a buy, sell or hold?
It's been a rough year on the price charts for Bath & Body Works, which was down more than 27% heading into Monday's session. Still, most of Wall Street has kept the faith on the consumer discretionary stock.
According to S&P Global Market Intelligence, the average analyst target price for BBWI stock is $42.76, representing implied upside of nearly 20% to current levels. Additionally, the consensus recommendation is a Buy.
Financial services firm UBS Global Research is taking a more cautious approach to the mid-cap stock, though, as evidenced by its a Neutral rating (equivalent to a Hold) and $38 price target.
"Our view is a soft category demand should weigh on BBWI's fiscal 2024 sales and earnings and limit the stock from outperforming," wrote UBS Global Research analyst Jay Sole in a November 7 note. "We see little chance of upside earnings surprises or price-to-earnings expansion in the near- to medium-term. Over the long term, we think BBWI could rebound and this is a main reason our rating is not Sell."
Related Content
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration.
-
Trade Uncertainty Sparks Whipsaw Session: Stock Market Today
Volatility is making a cameo here in mid-October, a generally positive month marked by its historic stock market events.
-
How to Add Your Passport to Google Wallet
Travelers can now store and use their digital passport on Android for faster, more secure airport experiences.
-
Trade Uncertainty Sparks Whipsaw Session: Stock Market Today
Volatility is making a cameo here in mid-October, a generally positive month marked by its historic stock market events.
-
Medicare Open Enrollment: Why You Need to Pay Extra Attention to Part D, From a Financial Adviser
The lowest premium for prescription drug coverage might not actually save you the most money. Make sure you take copays into consideration and do the math.
-
How the One Big Beautiful Bill Will Change Charitable Giving
Taxpayers who don't itemize will be able to take a bigger deduction for donations, which could boost giving. However, high-income donors could see their tax benefits reduced.
-
Stocks Swing in Volatile Session: Stock Market Today
The main indexes fell sharply in early trading on rising China tensions, but rebounded thanks to encouraging bank earnings.
-
A 'Fast, Fair and Friendly' Fail: Farmers Irks Customers With Its Handling of a Data Breach
Farmers Insurance is facing negative attention and lawsuits because of a three-month delay in notifying 1.1 million policyholders about a data breach. Here's what you can do if you're affected.
-
Serving the HNW Market: How Financial Advisers Can Break Through and Deliver Lasting Value
Financial advisers have a significant opportunity to serve high-net-worth clients by elevating their capabilities, delivering comprehensive planning, building diverse teams and prioritizing family wealth education.
-
Don't Just Sell, Connect: How Financial Advisers Can Ignite Their Sales Growth
Avoid complacency and embrace small, consistent improvements to optimize your sales process and results.
-
Dow Adds 587 Points as Stocks Bounce: Stock Market Today
The main indexes rebounded sharply Monday after President Trump took a calmer stance toward China.